Late‐Onset Oral Cenesthopathy With Dopaminergic Dysfunction: Therapeutic Response to Pramipexole in a Case With Suspected Prodromal Lewy Body Disease
Psychogeriatrics · 2025
DOI: 10.1111/psyg.70088 ↗Kurz gefasst
Fallbericht in der Zeitschrift Psychogeriatrics, 2025. Verfasst von Hitomi Matsui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tokyo Metropolitan Institute for Geriatrics and Gerontology, Itabashi, Japan. Hauptthemen laut MEDLINE: Pramipexole, Lewy Body Disease, Dopamine Agonists. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
An 85‐year‐old woman with late‐onset depression subsequently developed persistent oral cenesthopathy. As antidepressant augmentation, low‐dose aripiprazole improved both mood and oral symptoms, but oversedation and parkinsonism necessitated tapering and discontinuation. After discontinuation, oral cenesthopathy recurred without clear depressive worsening. Dopamine transporter single‐photon emission computed tomography showed reduced bilateral striatal uptake and 123 I‐metaiodobenzylguanidine cardiac scintigraphy showed decreased uptake, with preserved cognition. In light of the clinical and imaging findings suggestive of dopaminergic dysfunction, and after an informed discussion of off‐label use, pramipexole 0.25 mg daily was initiated. Oral discomfort lessened within 1 week and oral intake normalised by 2 weeks, without adverse effects; remission of oral symptoms and mood persisted for 6 months. Overall, the presentation was conceptually compatible with the psychiatric‐onset phenotype described in the prodromal Lewy body disease research framework, but this remains an interpretive consideration rather than a diagnosis. Assessing possible dopaminergic involvement in similar cases of oral cenesthopathy may aid individualised management; however, the therapeutic role of dopamine agonists requires confirmation in prospective studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tokyo Metropolitan Institute for Geriatrics and Gerontology, Itabashi, Japan.
- Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Japan.
- Center for Brain Integration Research, Institute of Science Tokyo, Japan.
ORCID-Profile: Hitomi Matsui
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Matsui, H., Tamura, T., Kameyama, M., Omori, Y., Sugihara, G., Takeuchi, T., Takahashi, H., & Furuta, K. (2025). Late‐Onset Oral Cenesthopathy With Dopaminergic Dysfunction: Therapeutic Response to Pramipexole in a Case With Suspected Prodromal Lewy Body Disease. Psychogeriatrics. https://doi.org/10.1111/psyg.70088
Vancouver
Matsui H, Tamura T, Kameyama M, Omori Y, Sugihara G, Takeuchi T, et al. Late‐Onset Oral Cenesthopathy With Dopaminergic Dysfunction: Therapeutic Response to Pramipexole in a Case With Suspected Prodromal Lewy Body Disease. Psychogeriatrics. 2025. doi:10.1111/psyg.70088
BibTeX
@article{Matsui2025,
author = {Matsui, Hitomi and Tamura, Takehiro and Kameyama, Masashi and Omori, Yuki and Sugihara, Genichi and Takeuchi, Takashi and Takahashi, Hidehiko and Furuta, Ko},
title = {Late‐Onset Oral Cenesthopathy With Dopaminergic Dysfunction: Therapeutic Response to Pramipexole in a Case With Suspected Prodromal Lewy Body Disease},
journal = {Psychogeriatrics},
year = {2025},
doi = {10.1111/psyg.70088}
}
EUVIMED